M. A. List

699 total citations
14 papers, 516 citations indexed

About

M. A. List is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. A. List has authored 14 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Otorhinolaryngology, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. A. List's work include Head and Neck Cancer Studies (10 papers), Lung Cancer Research Studies (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). M. A. List is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Lung Cancer Research Studies (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). M. A. List collaborates with scholars based in United States, Austria and Germany. M. A. List's co-authors include S. Pinar Bilir, C. Herrmann, Tina Dasgupta, Everett E. Vokes, Shirley B. Lansky, F.R. Hendrickson, Daniel J. Haraf, Alicia M. Siston, Patricia Mumby and Ellen MacCracken and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

M. A. List

14 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. A. List United States 9 268 263 210 136 75 14 516
Wynia Derks Netherlands 9 335 1.3× 145 0.6× 181 0.9× 195 1.4× 33 0.4× 11 494
Stewart M. Bond United States 14 136 0.5× 195 0.7× 151 0.7× 78 0.6× 43 0.6× 24 497
Lynn M. Steinbrenner United States 9 141 0.5× 160 0.6× 134 0.6× 71 0.5× 56 0.7× 18 356
M. Catherine Brown Canada 14 57 0.2× 213 0.8× 117 0.6× 91 0.7× 53 0.7× 75 549
George H. Petti United States 10 142 0.5× 132 0.5× 84 0.4× 138 1.0× 15 0.2× 18 343
Ewa Silander Sweden 13 533 2.0× 291 1.1× 362 1.7× 166 1.2× 61 0.8× 21 870
Elise Carper United States 6 291 1.1× 141 0.5× 133 0.6× 166 1.2× 20 0.3× 8 403
Ya‐Lan Chang Taiwan 10 74 0.3× 117 0.4× 47 0.2× 90 0.7× 25 0.3× 21 327
E. Meister Germany 10 207 0.8× 127 0.5× 112 0.5× 74 0.5× 17 0.2× 30 364
Alexandra Meyer Germany 9 103 0.4× 143 0.5× 80 0.4× 21 0.2× 40 0.5× 39 316

Countries citing papers authored by M. A. List

Since Specialization
Citations

This map shows the geographic impact of M. A. List's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. List with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. List more than expected).

Fields of papers citing papers by M. A. List

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. List. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. List. The network helps show where M. A. List may publish in the future.

Co-authorship network of co-authors of M. A. List

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. List. A scholar is included among the top collaborators of M. A. List based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. List. M. A. List is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Fleischmann, Edith, Thomas Christian, M. A. List, et al.. (2024). Desflurane versus sevoflurane anesthesia and postoperative recovery in older adults undergoing minor- to moderate-risk noncardiac surgery – A prospective, randomized, observer-blinded, clinical trial. Journal of Clinical Anesthesia. 98. 111576–111576. 2 indexed citations
2.
Ang, K. Kian, David I. Rosenthal, Phuc Félix Nguyen‐Tan, et al.. (2011). A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC).. Journal of Clinical Oncology. 29(15_suppl). 5500–5500. 124 indexed citations
3.
Ang, K. Kian, Thomas F. Pajak, David I. Rosenthal, et al.. (2007). A Phase III Trial to Compare Standard Versus Accelerated Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas (RTOG 0129): Report of Compliance and Toxicity. International Journal of Radiation Oncology*Biology*Physics. 69(3). S12–S13. 9 indexed citations
4.
Salama, Joseph K., Kerstin Stenson, Ezra E.W. Cohen, et al.. (2006). 24. International Journal of Radiation Oncology*Biology*Physics. 66(3). S14–S14. 5 indexed citations
5.
Vokes, Everett E., Kerstin Stenson, Emily O. Kistner, et al.. (2006). Sequential evaluation of reduced radiotherapy doses in a phase II trial of induction chemotherapy (IndCT) followed by concomitant chemoradiotherapy (CTX) for advanced head and neck cancer (HNC). Journal of Clinical Oncology. 24(18_suppl). 5528–5528. 4 indexed citations
6.
List, M. A. & S. Pinar Bilir. (2004). Functional outcomes in head and neck cancer. Seminars in Radiation Oncology. 14(2). 178–189. 85 indexed citations
8.
Mantz, C.A., Everett E. Vokes, M.S. Kies, et al.. (2001). Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Annals of Oncology. 12(3). 343–347. 25 indexed citations
9.
Mantz, C.A., Everett E. Vokes, Kerstin Stenson, et al.. (2001). Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.. PubMed. 7(2). 140–8. 23 indexed citations
10.
Mittal, Bharat B., M.S. Kies, Harold J. Pelzer, et al.. (2001). Use of IMRT to reduce toxicity from concomitant radiation and chemotherapy for advanced head and neck cancers. International Journal of Radiation Oncology*Biology*Physics. 51(3). 82–83. 5 indexed citations
11.
Lilenbaum, Rogério, M. A. List, & Christopher E. Desch. (1999). Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a meta-analysis and the Cancer and Leukemia Group B randomized trial.. PubMed. 26(5 Suppl 15). 52–4. 11 indexed citations
12.
Mani, Sridhar, J. W. Kugler, Rafat Ansari, et al.. (1998). Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: A University of Chicago phase II consortium study. Annals of Oncology. 9(9). 1035–1037. 14 indexed citations
13.
List, M. A., Patricia Mumby, Daniel J. Haraf, et al.. (1997). Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Quality of Life Research. 6(3). 274–284. 77 indexed citations
14.
Lansky, Shirley B., et al.. (1985). Absence of major depressive disorder in female cancer patients.. Journal of Clinical Oncology. 3(11). 1553–1560. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026